Drug reference

vosoritide

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1386, 1387, 1388

Overview

Names and pronunciation

(voe-SOR-i-tide) Voxzogo

PDF page 1386

Functional class

Func. class.: Misc. agent affecting bone structure

PDF page 1386

Uses

USES: Increase linear growth in pediatric patients with achondroplasia

PDF page 1387

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Child: SUBCUT based on body weight

PDF page 1387

Available forms

Available forms: Lyophilized powder for injection 0.4 mg, 0.56 mg, 1.2 mg single-dose vial V HIGH ALERT

PDF pages 1387, 1388

Dose text by age group

Child

• Child: SUBCUT based on body weight

PDF page 1387

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

vosoritide

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1386, 1387, 1388

Overview

Names and pronunciation

(voe-SOR-i-tide) Voxzogo

PDF page 1386

Functional class

Func. class.: Misc. agent affecting bone structure

PDF page 1386

Uses

USES: Increase linear growth in pediatric patients with achondroplasia

PDF page 1387

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES • Child: SUBCUT based on body weight

PDF page 1387

Available forms

Available forms: Lyophilized powder for injection 0.4 mg, 0.56 mg, 1.2 mg single-dose vial V HIGH ALERT

PDF pages 1387, 1388

Dose text by age group

Child

• Child: SUBCUT based on body weight

PDF page 1387

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.